Associated Genetic Biomarkers

Overview

NCI Definition: A neoplasm composed of a lymphocytic cell population which is usually malignant (clonal) by molecular genetic and/or immunophenotypic analysis. Lymphocytic neoplasms include Hodgkin and non-Hodgkin lymphomas, acute and chronic lymphocytic leukemias, and plasma cell neoplasms. [1]

Significant Genes in Lymphocytic Neoplasm

FGFR1 +

FGFR2 +

FGFR3 +

FGFR4 +

Disease Details

Synonyms
Lymphoid and Plasmacytic Tumour, Lymphoid and Plasma Cell Tumor, Lymphocytic and Plasma Cell Tumour, Lymphoid Tumor, Lymphocytic and Plasmacytic Neoplasm, Lymphoid and Plasmacytic Neoplasm, Lymphoid Neoplasm, Lymphocytic and Plasma Cell Tumor, Lymphocytic and Plasma Cell Neoplasm, Lymphoid and Plasma Cell Tumour, Lymphoid and Plasmacytic Tumor, Lymphocytic Tumor
Parent(s)
Lymphoproliferative Disorder
Children
B-Cell Neoplasm, Lymphoid Leukemia, Angiocentric Immunoproliferative Lesion, T-Cell and NK-Cell Neoplasm, and Lymphoma
OncoTree Name
Lymphoid Neoplasm
OncoTree Code
LNM

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.